AstraZeneca Q3 Sales Rise 'Is Milestone', CEO Soriot 'Not Leaving'

AstraZeneca's third-quarter results show it has emerged from a long decline and returned to growth, fuelled by new products and pipeline, the UK pharma's CEO Pascal Soriot told reporters, adding that he's having too much fun turning the group around to leave any time soon.